Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-07-06FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC. The action finalizes the r…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Effects of Anthocyans on Cardiovascular and Sympathetic Function [NA]
A completed clinical trial examining the effects of anthocyans (anthocyanins) on cardiovascular and sympathetic function in hypertension.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL) [Phase 4]
Phase 4 trial update on losartan for glucose optimization in hypertension has completed. The GOAAL study was sponsored by Ullevaal Universit…
-
FDA approval · 2011-07-05FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of enalapril maleate and hydrochlorothiazide by Taro Pharma…
-
FDA approval · 2011-07-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's generic fixed-dose combination of amlodipine besylate and benazepril hydrochloride for hypertension under an original A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-07-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original application for amlodipine besylate and benazepril hydrochloride tablets from Dr. Reddy's Laboratories Limited, a …
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Risk Assessment and Treat Compliance in Hypertension Education Trial [NA]
This update reports on a completed clinical trial focused on risk assessment and treatment compliance in hypertension education.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics) [Phase 3]
This Phase 3 trial update reports the long-term clinical experience with Atacand (candesartan) in hypertensive children aged 1 to under 11 y…
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise [Phase 2]
Phase 2 trial results evaluate the efficacy and safety of aliskiren in patients with mild to moderate hypertension during exercise.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Self-monitoring of Blood Pressure in Primary Care [NA]
This clinical trial update concerns self-monitoring of blood pressure in primary care. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of combining aliskiren with amlodipine versus amlodipine alone in patients with moderate …
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy [Phase 4]
Phase 4 prospective clinical trial evaluating whether aliskiren can protect kidney function in hypertensive patients with IgA nephropathy.
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes [EARLY_Phase 1]
An early-phase clinical trial update evaluating whether computerized decision support can reduce racial/ethnic disparities in hypertension o…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study [Phase 1]
Phase 1 bioavailability study to assess bioequivalence of lisinopril 40 mg tablets under fed conditions.
-
FDA approval · 2011-06-24FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental NDA for ATACAND (candesartan cilexetil), resulting in an updated product label. This acti…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Morning Hypertension and Preminent Therapy Study [Phase 4]
Phase 4 clinical trial completed evaluating morning hypertension and a therapy called Preminent Therapy conducted by Kurume University.
-
CLINICAL_TRIALS withdrawal · 2011-06-22Clinical Trial Update: Accuracy of Non-Invasive Blood Pressure Measurement in Adults
A clinical trial evaluating the accuracy of a non-invasive blood pressure device in adults has been withdrawn; sponsor is Sotera Wireless, I…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension [Phase 4]
This Phase 4 trial compares GI safety and tolerability of aliskiren versus ramipril in adults with essential hypertension, with results post…
-
FDA approval · 2011-06-20FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study [Phase 3]
Phase 3 trial evaluating the efficacy and safety of aliskiren at 75 mg, 150 mg, and 300 mg in elderly patients with essential hypertension w…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension [Phase 1]
Phase 1 trial comparing naproxcinod to naproxen and ibuprofen to assess effects on arterial blood pressure in osteoarthritis patients with c…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure [Phase 1]
Phase 1 trial evaluating the blood pressure effects of Naproxcinod versus Naproxen in osteoarthritis patients with controlled hypertension.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria [Phase 4]
Phase 4 trial update indicating completion of the ADDM study evaluating Amtrel (amlodipine) and Co-Diovan (losartan/hydrochlorothiazide) in …
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension [Phase 3]
Phase 3 Russian study updates the effect of continuous positive airway pressure (CPAP) on hypertension in obstructive sleep apnea patients; …
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone [Phase 3]
A Phase 3 study evaluated whether adding amlodipine to aliskiren improves blood pressure control in hypertension patients not adequately res…